<?xml version="1.0" encoding="UTF-8"?>
  	<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url>
      <loc>https://www.ajmc.com/view/disability-economic-toll-of-multimorbidity-climb-in-older-adults</loc><lastmod>2026-10-30T20:17:32.224Z</lastmod><news:news><news:publication_date>2026-10-30T20:17:32.224Z</news:publication_date>
        <news:title><![CDATA[Disability, Economic Toll of Multimorbidity Climb in Older Adults ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/faq-pbm-reform-340b-and-medicare-shifts-payers-face-in-2027</loc><lastmod>2026-10-30T19:48:42.336Z</lastmod><news:news><news:publication_date>2026-10-30T19:48:42.336Z</news:publication_date>
        <news:title><![CDATA[FAQ: PBM Reform, 340B, and Medicare Shifts Payers Face in 2027]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bronchiectasis-is-underrecognized-obada-shamaa-md-phd</loc><lastmod>2026-10-30T18:51:06.595Z</lastmod><news:news><news:publication_date>2026-10-30T18:51:06.595Z</news:publication_date>
        <news:title><![CDATA[Bronchiectasis Is Underrecognized: Obada Shamaa, MD, PhD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/evidence-based-treatment-guidelines-and-advances-in-therapeutic-agents</loc><lastmod>2026-10-30T18:48:49.080Z</lastmod><news:news><news:publication_date>2026-10-30T18:48:49.080Z</news:publication_date>
        <news:title><![CDATA[Evidence-Based Treatment Guidelines and Advances in Therapeutic Agents]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/duchenne-muscular-dystrophy-understanding-pathophysiology-and-disease-burden</loc><lastmod>2026-10-30T18:48:49.080Z</lastmod><news:news><news:publication_date>2026-10-30T18:48:49.080Z</news:publication_date>
        <news:title><![CDATA[Duchenne Muscular Dystrophy: Understanding Pathophysiology and Disease Burden]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/managed-care-strategies-and-considerations</loc><lastmod>2026-10-30T18:48:49.080Z</lastmod><news:news><news:publication_date>2026-10-30T18:48:49.080Z</news:publication_date>
        <news:title><![CDATA[Managed Care Strategies and Considerations]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bispecific-program-design-varies-by-practice-size-experts-say</loc><lastmod>2026-10-30T16:40:23.540Z</lastmod><news:news><news:publication_date>2026-10-30T16:40:23.540Z</news:publication_date>
        <news:title><![CDATA[Bispecific Program Design Varies by Practice Size, Experts Say]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/shortening-the-road-to-a-bipolar-diagnosis-justin-t-ray-pmhnp-bc</loc><lastmod>2026-10-30T16:37:00.983Z</lastmod><news:news><news:publication_date>2026-10-30T16:37:00.983Z</news:publication_date>
        <news:title><![CDATA[Shortening the Road to a Bipolar Diagnosis: Justin T. Ray, PMHNP-BC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/vibegron-persistence-near-60-at-1-year-in-real-world-oab-study</loc><lastmod>2026-10-30T16:28:38.072Z</lastmod><news:news><news:publication_date>2026-10-30T16:28:38.072Z</news:publication_date>
        <news:title><![CDATA[Vibegron Persistence Near 60% at 1 Year in Real-World OAB Study]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/machine-learning-models-flag-nonobese-masld-using-routine-blood-tests</loc><lastmod>2026-10-30T16:16:22.198Z</lastmod><news:news><news:publication_date>2026-10-30T16:16:22.198Z</news:publication_date>
        <news:title><![CDATA[Machine Learning Models Flag Nonobese MASLD Using Routine Blood Tests]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pharmacists-take-on-education-and-toxicity-triage-in-bispecific-care</loc><lastmod>2026-10-30T15:16:57.634Z</lastmod><news:news><news:publication_date>2026-10-30T15:16:57.634Z</news:publication_date>
        <news:title><![CDATA[Pharmacists Take On Education and Toxicity Triage in Bispecific Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/weekly-gefurulimab-improves-daily-function-in-generalized-mg</loc><lastmod>2026-10-30T14:38:57.821Z</lastmod><news:news><news:publication_date>2026-10-30T14:38:57.821Z</news:publication_date>
        <news:title><![CDATA[Weekly Gefurulimab Improves Daily Function in Generalized MG]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/small-studies-show-high-upadacitinib-response-in-alopecia-areata</loc><lastmod>2026-10-30T14:20:00Z</lastmod><news:news><news:publication_date>2026-10-30T14:20:00Z</news:publication_date>
        <news:title><![CDATA[Small Studies Show High Upadacitinib Response in Alopecia Areata]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/kidney-week-2026-recap-igan-advances-value-based-care-ckd-care-gaps</loc><lastmod>2026-10-30T13:24:02.089Z</lastmod><news:news><news:publication_date>2026-10-30T13:24:02.089Z</news:publication_date>
        <news:title><![CDATA[Kidney Week 2026 Recap: IgAN Advances, Value-Based Care, CKD Care Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bispecific-intensification-yields-73-mrd-negative-cr-rate-in-high-risk-newly-diagnosed-myeloma</loc><lastmod>2026-10-30T12:07:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:07:00Z</news:publication_date>
        <news:title><![CDATA[Bispecific Intensification Yields 73% MRD-Negative CR Rate in High-Risk Newly Diagnosed Myeloma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ms-progression-explained-relapse-associated-worsening-vs-pira</loc><lastmod>2026-10-30T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[MS Progression Explained: Relapse-Associated Worsening vs PIRA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/selecting-first-line-therapy-in-egfr-exon-20-nsclc-toxicity-and-monitoring</loc><lastmod>2026-10-30T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Selecting First-Line Therapy in EGFR Exon 20 NSCLC: Toxicity and Monitoring]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/how-bronchiectasis-feels-symptoms-and-daily-patient-burden</loc><lastmod>2026-10-30T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:05:00Z</news:publication_date>
        <news:title><![CDATA[How Bronchiectasis Feels: Symptoms and Daily Patient Burden]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bronchiectasis-explained-pathophysiology-prevalence-and-evolving-models</loc><lastmod>2026-10-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Bronchiectasis Explained: Pathophysiology, Prevalence, and Evolving Models]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ms-epidemiology-who-is-affected-and-where-unmet-need-remains</loc><lastmod>2026-10-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[MS Epidemiology: Who Is Affected and Where Unmet Need Remains]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/egfr-exon-20-insertion-nsclc-prevalence-testing-and-standard-of-care</loc><lastmod>2026-10-30T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-30T12:00:00Z</news:publication_date>
        <news:title><![CDATA[EGFR Exon 20 Insertion NSCLC: Prevalence, Testing, and Standard of Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/precision-medicine-adoption-hindered-by-coverage-education-gaps</loc><lastmod>2026-10-29T21:00:00Z</lastmod><news:news><news:publication_date>2026-10-29T21:00:00Z</news:publication_date>
        <news:title><![CDATA[Precision Medicine Adoption Hindered by Coverage, Education Gaps]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/logistics-payer-rules-and-care-coordination-shape-access-to-cancer-innovation</loc><lastmod>2026-10-29T20:50:00Z</lastmod><news:news><news:publication_date>2026-10-29T20:50:00Z</news:publication_date>
        <news:title><![CDATA[Logistics, Payer Rules, and Care Coordination Shape Access to Cancer Innovation]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-gap-between-new-ckd-therapies-and-patients-who-need-them</loc><lastmod>2026-10-29T20:01:52.681Z</lastmod><news:news><news:publication_date>2026-10-29T20:01:52.681Z</news:publication_date>
        <news:title><![CDATA[Closing the Gap Between New CKD Therapies and Patients Who Need Them ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/right-diagnosis-is-key-to-treating-bipolar-justin-t-ray-pmhnp-bc</loc><lastmod>2026-10-29T19:57:55.091Z</lastmod><news:news><news:publication_date>2026-10-29T19:57:55.091Z</news:publication_date>
        <news:title><![CDATA[Right Diagnosis Is Key to Treating Bipolar: Justin T. Ray, PMHNP-BC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/elagolix-noninferior-to-dienogest-for-endometriosis-pain-in-phase-3-trial</loc><lastmod>2026-10-29T19:45:09.419Z</lastmod><news:news><news:publication_date>2026-10-29T19:45:09.419Z</news:publication_date>
        <news:title><![CDATA[Elagolix Noninferior to Dienogest for Endometriosis Pain in Phase 3 Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/closing-the-gap-from-hcv-diagnosis-to-cure-norah-terrault-md-mph</loc><lastmod>2026-10-29T19:40:37.622Z</lastmod><news:news><news:publication_date>2026-10-29T19:40:37.622Z</news:publication_date>
        <news:title><![CDATA[Closing the Gap From HCV Diagnosis to Cure: Norah Terrault, MD, MPH]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/frontal-fibrosing-alopecia-treatment-largely-similar-in-black-white-patients</loc><lastmod>2026-10-29T17:45:20.710Z</lastmod><news:news><news:publication_date>2026-10-29T17:45:20.710Z</news:publication_date>
        <news:title><![CDATA[Frontal Fibrosing Alopecia Treatment Largely Similar in Black, White Patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/remote-expert-review-finds-care-gaps-in-most-cancer-cases-yields-savings-when-adopted</loc><lastmod>2026-10-29T17:35:00Z</lastmod><news:news><news:publication_date>2026-10-29T17:35:00Z</news:publication_date>
        <news:title><![CDATA[Remote Expert Review Finds Care Gaps in Most Cancer Cases, Yields Savings When Adopted]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/masld-overlaps-with-nearly-half-of-chronic-viral-hepatitis-cases</loc><lastmod>2026-10-29T17:26:33.107Z</lastmod><news:news><news:publication_date>2026-10-29T17:26:33.107Z</news:publication_date>
        <news:title><![CDATA[MASLD Overlaps With Nearly Half of Chronic Viral Hepatitis Cases]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/four-major-idiopathic-pulmonary-fibrosis-advances-from-2026</loc><lastmod>2026-10-29T17:23:54.305Z</lastmod><news:news><news:publication_date>2026-10-29T17:23:54.305Z</news:publication_date>
        <news:title><![CDATA[Four Major Idiopathic Pulmonary Fibrosis Advances From 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/antibody-function-predicts-efgartigimod-response-in-myasthenia-gravis</loc><lastmod>2026-10-29T17:17:35.454Z</lastmod><news:news><news:publication_date>2026-10-29T17:17:35.454Z</news:publication_date>
        <news:title><![CDATA[Antibody Function Predicts Efgartigimod Response in Myasthenia Gravis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/5-things-to-know-about-hhs-s-interim-peptide-compounding-policy</loc><lastmod>2026-10-29T17:09:01.922Z</lastmod><news:news><news:publication_date>2026-10-29T17:09:01.922Z</news:publication_date>
        <news:title><![CDATA[5 Things to Know About HHS's Interim Peptide Compounding Policy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/hhs-draft-policy-eases-enforcement-on-6-compounded-peptides</loc><lastmod>2026-10-29T16:55:01.827Z</lastmod><news:news><news:publication_date>2026-10-29T16:55:01.827Z</news:publication_date>
        <news:title><![CDATA[HHS Draft Policy Eases Enforcement on 6 Compounded Peptides]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/single-cilta-cel-infusion-leaves-half-of-patients-with-early-line-myeloma-progression-free-at-5-years</loc><lastmod>2026-10-29T16:38:00Z</lastmod><news:news><news:publication_date>2026-10-29T16:38:00Z</news:publication_date>
        <news:title><![CDATA[Single Cilta-cel Infusion Leaves Half of Patients With Early-Line Myeloma Progression-Free at 5 Years]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ajmc-in-the-press-october-30-2026</loc><lastmod>2026-10-29T15:34:36.042Z</lastmod><news:news><news:publication_date>2026-10-29T15:34:36.042Z</news:publication_date>
        <news:title><![CDATA[AJMC® in the Press, October 30, 2026]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/experts-pitch-national-risk-pool-to-fund-gene-therapy-access</loc><lastmod>2026-10-29T14:36:10.922Z</lastmod><news:news><news:publication_date>2026-10-29T14:36:10.922Z</news:publication_date>
        <news:title><![CDATA[Experts Pitch National Risk Pool to Fund Gene Therapy Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bpc-157-wolverine-peptide-use-rose-33-fold-despite-scant-evidence</loc><lastmod>2026-10-29T14:33:04.543Z</lastmod><news:news><news:publication_date>2026-10-29T14:33:04.543Z</news:publication_date>
        <news:title><![CDATA[BPC-157 'Wolverine Peptide' Use Rose 33-Fold Despite Scant Evidence]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/how-capitation-and-crowded-eds-shape-who-gets-access-to-menin-inhibitors-in-aml</loc><lastmod>2026-10-29T14:15:00.000Z</lastmod><news:news><news:publication_date>2026-10-29T14:15:00Z</news:publication_date>
        <news:title><![CDATA[How Capitation and Crowded EDs Shape Who Gets Access to Menin Inhibitors in AML]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/frailty-linked-to-urinary-symptoms-in-adults-with-and-without-hiv</loc><lastmod>2026-10-29T14:00:00Z</lastmod><news:news><news:publication_date>2026-10-29T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Frailty Linked to Urinary Symptoms in Adults With and Without HIV]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/obesity-deserves-diabetes-level-coverage-fatima-cody-stanford-md</loc><lastmod>2026-10-29T13:04:00Z</lastmod><news:news><news:publication_date>2026-10-29T13:04:00Z</news:publication_date>
        <news:title><![CDATA[Obesity Deserves Diabetes-Level Coverage: Fatima Cody Stanford, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/approval-is-just-one-piece-of-the-specialty-drug-pie</loc><lastmod>2026-10-29T12:57:55.263Z</lastmod><news:news><news:publication_date>2026-10-29T12:57:55.263Z</news:publication_date>
        <news:title><![CDATA[Approval Is Just One Piece of the Specialty Drug Pie]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/stem-cell-transplant-timing-and-intensive-chemotherapy-trade-offs-in-aml</loc><lastmod>2026-10-29T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-29T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Stem Cell Transplant Timing and Intensive Chemotherapy Trade-offs in AML]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/newly-diagnosed-aml-treatment-goals-and-current-standard-of-care-regimens</loc><lastmod>2026-10-29T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-29T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Newly Diagnosed AML: Treatment Goals and Current Standard-of-Care Regimens]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-plans-juggle-the-hope-high-costs-of-rare-disease-drugs</loc><lastmod>2026-10-28T22:25:21.339Z</lastmod><news:news><news:publication_date>2026-10-28T22:25:21.339Z</news:publication_date>
        <news:title><![CDATA[Health Plans Juggle the Hope, High Costs of Rare Disease Drugs]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/most-patients-with-oab-report-symptom-improvement-at-nearly-3-years</loc><lastmod>2026-10-28T20:27:15.646Z</lastmod><news:news><news:publication_date>2026-10-28T20:27:15.646Z</news:publication_date>
        <news:title><![CDATA[Most Patients With OAB Report Symptom Improvement at Nearly 3 Years]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/alternating-prp-steroid-injections-lower-salt-scores-in-pediatric-aa</loc><lastmod>2026-10-28T20:21:14.099Z</lastmod><news:news><news:publication_date>2026-10-28T20:21:14.099Z</news:publication_date>
        <news:title><![CDATA[Alternating PRP, Steroid Injections Lower SALT Scores in Pediatric AA]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/340b-reform-pbm-policy-among-2027-issues-to-watch-adam-colborn-jd</loc><lastmod>2026-10-28T20:15:21.785Z</lastmod><news:news><news:publication_date>2026-10-28T20:15:21.785Z</news:publication_date>
        <news:title><![CDATA[340B Reform, PBM Policy Among 2027 Issues to Watch: Adam Colborn, JD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/crystal-clear-what-availity-s-founding-story-teaches-about-price-transparency</loc><lastmod>2026-10-28T20:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T20:00:00Z</news:publication_date>
        <news:title><![CDATA[Crystal Clear: What Availity's Founding Story Teaches About Price Transparency]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-data-link-cabotegravir-prep-to-few-hiv-cases-higher-adherence</loc><lastmod>2026-10-28T19:17:10.384Z</lastmod><news:news><news:publication_date>2026-10-28T19:17:10.384Z</news:publication_date>
        <news:title><![CDATA[New Data Link Cabotegravir PrEP to Few HIV Cases, Higher Adherence]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/antifibrotic-dose-reduction-not-tied-to-faster-ipf-progression</loc><lastmod>2026-10-28T19:15:50.927Z</lastmod><news:news><news:publication_date>2026-10-28T19:15:50.927Z</news:publication_date>
        <news:title><![CDATA[Antifibrotic Dose Reduction Not Tied to Faster IPF Progression]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/mirabegron-not-tied-to-higher-obesity-related-neoplasm-risk-in-oab</loc><lastmod>2026-10-28T18:49:48.815Z</lastmod><news:news><news:publication_date>2026-10-28T18:49:48.815Z</news:publication_date>
        <news:title><![CDATA[Mirabegron Not Tied to Higher Obesity-Related Neoplasm Risk in OAB]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/real-world-resmetirom-data-look-promising-in-mash-naim-alkhouri-md</loc><lastmod>2026-10-28T18:45:04.411Z</lastmod><news:news><news:publication_date>2026-10-28T18:45:04.411Z</news:publication_date>
        <news:title><![CDATA[Real-World Resmetirom Data Look Promising in MASH: Naim Alkhouri, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/sputum-color-tracks-inflammation-brensocatib-effect-in-bronchiectasis</loc><lastmod>2026-10-28T18:41:07.737Z</lastmod><news:news><news:publication_date>2026-10-28T18:41:07.737Z</news:publication_date>
        <news:title><![CDATA[Sputum Color Tracks Inflammation, Brensocatib Effect in Bronchiectasis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/opportunities-remain-as-us-biosimilar-adoption-advances</loc><lastmod>2026-10-28T18:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T18:00:00Z</news:publication_date>
        <news:title><![CDATA[Opportunities Remain as US Biosimilar Adoption Advances]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/thyme-care-texas-oncology-cut-723k-in-pembrolizumab-spending-with-weight-based-dosing</loc><lastmod>2026-10-28T17:03:00Z</lastmod><news:news><news:publication_date>2026-10-28T17:03:00Z</news:publication_date>
        <news:title><![CDATA[Thyme Care, Texas Oncology Cut $723K in Pembrolizumab Spending With Weight-Based Dosing]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/patient-experience-data-offer-value-but-pose-evaluation-challenges</loc><lastmod>2026-10-28T16:15:41.583Z</lastmod><news:news><news:publication_date>2026-10-28T16:15:41.583Z</news:publication_date>
        <news:title><![CDATA[Patient Experience Data Offer Value but Pose Evaluation Challenges]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/learning-health-system-characteristics-and-burnout-in-primary-care</loc><lastmod>2026-10-28T16:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T16:00:00Z</news:publication_date>
        <news:title><![CDATA[Learning Health System Characteristics and Burnout in Primary Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/biosimilar-entry-should-trigger-a-fresh-look-at-biologic-access</loc><lastmod>2026-10-28T15:31:43.441Z</lastmod><news:news><news:publication_date>2026-10-28T15:31:43.441Z</news:publication_date>
        <news:title><![CDATA[Biosimilar Entry Should Trigger a Fresh Look at Biologic Access]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/telehealth-overtakes-travel-in-states-with-total-abortion-bans</loc><lastmod>2026-10-28T15:10:35.896Z</lastmod><news:news><news:publication_date>2026-10-28T15:10:35.896Z</news:publication_date>
        <news:title><![CDATA[Telehealth Overtakes Travel in States With Total Abortion Bans]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/retatrutide-tops-semaglutide-on-a1c-weight-in-head-to-head-trial</loc><lastmod>2026-10-28T14:46:35.610Z</lastmod><news:news><news:publication_date>2026-10-28T14:46:35.610Z</news:publication_date>
        <news:title><![CDATA[Retatrutide Tops Semaglutide on A1C, Weight in Head-to-Head Trial]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/health-literacy-drives-trial-access-oyepeju-abioye-akintola-md-msc</loc><lastmod>2026-10-28T14:43:56.641Z</lastmod><news:news><news:publication_date>2026-10-28T14:43:56.641Z</news:publication_date>
        <news:title><![CDATA[Health Literacy Drives Trial Access: Oyepeju Abioye-Akintola, MD, MSc]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/aml-experts-favor-menin-inhibitor-combinations-warn-of-late-differentiation-syndrome</loc><lastmod>2026-10-28T14:15:00Z</lastmod><news:news><news:publication_date>2026-10-28T14:15:00Z</news:publication_date>
        <news:title><![CDATA[AML Experts Favor Menin Inhibitor Combinations, Warn of Late Differentiation Syndrome]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/who-defines-autism-care-single-discipline-guidelines-risk-distorting-health-policy-in-the-us</loc><lastmod>2026-10-28T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Who Defines Autism Care? Single-Discipline Guidelines Risk Distorting Health Policy in the US]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/lifileucel-shows-50-response-rate-in-refractory-ups-and-liposarcoma</loc><lastmod>2026-10-28T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Lifileucel Shows 50% Response Rate in Refractory UPS and Liposarcoma]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/fast-moving-all-care-outpaces-guidelines-emily-k-curran-md</loc><lastmod>2026-10-28T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Fast-Moving ALL Care Outpaces Guidelines: Emily K. Curran, MD ]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/uab-works-to-deliver-cutting-edge-cancer-therapies-reach-every-patient</loc><lastmod>2026-10-28T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T13:00:00Z</news:publication_date>
        <news:title><![CDATA[UAB Works to Deliver Cutting-Edge Cancer Therapies, Reach Every Patient]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/aatd-augmentation-adherence-infusion-burden-and-plasma-supply</loc><lastmod>2026-10-28T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-28T12:05:00Z</news:publication_date>
        <news:title><![CDATA[AATD Augmentation Adherence, Infusion Burden, and Plasma Supply]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/caspian-and-impower133-comparing-frontline-trials-in-extensive-stage-sclc</loc><lastmod>2026-10-28T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-28T12:05:00Z</news:publication_date>
        <news:title><![CDATA[CASPIAN and IMpower133: Comparing Frontline Trials in Extensive-Stage SCLC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/extensive-stage-sclc-the-case-for-adding-immunotherapy</loc><lastmod>2026-10-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Extensive-Stage SCLC: The Case for Adding Immunotherapy]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/weekly-aatd-infusions-peak-to-trough-levels-in-practice</loc><lastmod>2026-10-28T12:00:00Z</lastmod><news:news><news:publication_date>2026-10-28T12:00:00Z</news:publication_date>
        <news:title><![CDATA[Weekly AATD Infusions: Peak-to-Trough Levels in Practice]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/at-the-pharmacy-affordability-connects-policy-plans-and-patients</loc><lastmod>2026-10-28T01:56:44.211Z</lastmod><news:news><news:publication_date>2026-10-28T01:56:44.211Z</news:publication_date>
        <news:title><![CDATA[At the Pharmacy, Affordability Connects Policy, Plans, and Patients]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/start-small-to-scale-ai-in-managed-care-leanna-baker-pharmd-ms</loc><lastmod>2026-10-28T01:52:52.377Z</lastmod><news:news><news:publication_date>2026-10-28T01:52:52.377Z</news:publication_date>
        <news:title><![CDATA[Start Small to Scale AI in Managed Care: Leanna Baker, PharmD, MS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/preparing-payers-for-the-next-wave-of-specialty-therapies</loc><lastmod>2026-10-28T01:16:17.614Z</lastmod><news:news><news:publication_date>2026-10-28T01:16:17.614Z</news:publication_date>
        <news:title><![CDATA[Preparing Payers for the Next Wave of Specialty Therapies]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/the-dtc-glp-1-boom-solved-access-can-it-solve-adherence</loc><lastmod>2026-10-27T21:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T21:00:00Z</news:publication_date>
        <news:title><![CDATA[The DTC GLP-1 Boom Solved Access. Can It Solve Adherence?]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/olanzapine-samidorphan-tied-to-longer-persistence-in-schizophrenia</loc><lastmod>2026-10-27T20:35:23.081Z</lastmod><news:news><news:publication_date>2026-10-27T20:35:23.081Z</news:publication_date>
        <news:title><![CDATA[Olanzapine/Samidorphan Tied to Longer Persistence in Schizophrenia]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/review-finds-ms-is-an-underrecognized-cause-of-acute-vertigo</loc><lastmod>2026-10-27T19:10:57.882Z</lastmod><news:news><news:publication_date>2026-10-27T19:10:57.882Z</news:publication_date>
        <news:title><![CDATA[Review Finds MS Is an Underrecognized Cause of Acute Vertigo]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/idweek-2026-recap-care-gaps-and-value-of-collaboration</loc><lastmod>2026-10-27T18:39:54.799Z</lastmod><news:news><news:publication_date>2026-10-27T18:39:54.799Z</news:publication_date>
        <news:title><![CDATA[IDWeek 2026 Recap: Care Gaps and Value of Collaboration]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/faq-ways-health-plans-can-assist-members-in-medicaid-redetermination</loc><lastmod>2026-10-27T17:59:34.373Z</lastmod><news:news><news:publication_date>2026-10-27T17:59:34.373Z</news:publication_date>
        <news:title><![CDATA[FAQ: Ways Health Plans Can Assist Members in Medicaid Redetermination]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/povetacicept-cuts-proteinuria-in-igan-richard-lafayette</loc><lastmod>2026-10-27T17:45:33.404Z</lastmod><news:news><news:publication_date>2026-10-27T17:45:33.404Z</news:publication_date>
        <news:title><![CDATA[Povetacicept Cuts Proteinuria in IgAN: Richard Lafayette, MD, FACP]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/youths-with-depression-face-higher-odds-of-prescription-drug-misuse</loc><lastmod>2026-10-27T17:45:12.750Z</lastmod><news:news><news:publication_date>2026-10-27T17:45:12.750Z</news:publication_date>
        <news:title><![CDATA[Youths With Depression Face Higher Odds of Prescription Drug Misuse]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/real-world-efgartigimod-data-can-guide-gmg-care-emily-chen-pharmd-bcpps</loc><lastmod>2026-10-27T17:38:27.972Z</lastmod><news:news><news:publication_date>2026-10-27T17:38:27.972Z</news:publication_date>
        <news:title><![CDATA[Real-World Efgartigimod Data Can Guide gMG Care: Emily Chen, PharmD, BCPPS]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/zidesamtinib-added-to-nccn-guidelines-for-pretreated-ros1-nsclc</loc><lastmod>2026-10-27T17:33:34.397Z</lastmod><news:news><news:publication_date>2026-10-27T17:33:34.397Z</news:publication_date>
        <news:title><![CDATA[Zidesamtinib Added to NCCN Guidelines for Pretreated ROS1+ NSCLC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/medicare-plan-terminations-hit-4-3-million-as-part-d-market-shrinks</loc><lastmod>2026-10-27T17:27:45.424Z</lastmod><news:news><news:publication_date>2026-10-27T17:27:45.424Z</news:publication_date>
        <news:title><![CDATA[Medicare Plan Terminations Hit 4.3 Million as Part D Market Shrinks]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/anti-cgrp-antibody-exposure-near-conception-linked-to-miscarriage-risk</loc><lastmod>2026-10-27T17:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T17:00:00Z</news:publication_date>
        <news:title><![CDATA[Anti-CGRP Antibody Exposure Near Conception Linked to Miscarriage Risk]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/mrd-could-decide-when-myeloma-maintenance-ends-prerna-mewawalla-md</loc><lastmod>2026-10-27T16:26:02.752Z</lastmod><news:news><news:publication_date>2026-10-27T16:26:02.752Z</news:publication_date>
        <news:title><![CDATA[MRD Could Decide When Myeloma Maintenance Ends: Prerna Mewawalla, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/mri-has-selective-role-after-expert-ultrasound-in-deep-endometriosis</loc><lastmod>2026-10-27T16:15:35.389Z</lastmod><news:news><news:publication_date>2026-10-27T16:15:35.389Z</news:publication_date>
        <news:title><![CDATA[MRI Has Selective Role After Expert Ultrasound in Deep Endometriosis]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/external-validation-and-adaptation-of-the-cambridge-multimorbidity-score-using-german-claims-data</loc><lastmod>2026-10-27T16:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T16:00:00Z</news:publication_date>
        <news:title><![CDATA[External Validation and Adaptation of the Cambridge Multimorbidity Score Using German Claims Data]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/pcoc-recap-seven-leaders-define-patient-centered-oncology-care</loc><lastmod>2026-10-27T16:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T16:00:00Z</news:publication_date>
        <news:title><![CDATA[PCOC Recap: Seven Leaders Define Patient-Centered Oncology Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/new-apac-consensus-guides-alopecia-areata-care-across-8-countries</loc><lastmod>2026-10-27T14:01:00Z</lastmod><news:news><news:publication_date>2026-10-27T14:01:00Z</news:publication_date>
        <news:title><![CDATA[New APAC Consensus Guides Alopecia Areata Care Across 8 Countries]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/bridging-distance-delivery-gaps-in-cancer-care</loc><lastmod>2026-10-27T14:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T14:00:00Z</news:publication_date>
        <news:title><![CDATA[Bridging Distance, Delivery Gaps in Cancer Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/payers-health-systems-should-look-beyond-the-icu-chest-2026-recap</loc><lastmod>2026-10-27T13:38:02.900Z</lastmod><news:news><news:publication_date>2026-10-27T13:38:02.900Z</news:publication_date>
        <news:title><![CDATA[Payers, Health Systems Should Look Beyond the ICU: CHEST 2026 Recap]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/diagnosing-ih-when-the-mslt-is-normal-logan-schneider-md</loc><lastmod>2026-10-27T13:37:00Z</lastmod><news:news><news:publication_date>2026-10-27T13:37:00Z</news:publication_date>
        <news:title><![CDATA[Diagnosing IH When the MSLT Is Normal: Logan Schneider, MD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/menin-inhibitors-in-aml-in-nyc-experts-map-the-path-from-academic-centers-to-community-care</loc><lastmod>2026-10-27T13:01:00Z</lastmod><news:news><news:publication_date>2026-10-27T13:01:00Z</news:publication_date>
        <news:title><![CDATA[Menin Inhibitors in AML: In NYC, Experts Map the Path From Academic Centers to Community Care]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/rapid-increase-in-topical-diclofenac-use-for-chronic-pain-2011-2020</loc><lastmod>2026-10-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[Rapid Increase in Topical Diclofenac Use for Chronic Pain, 2011-2020]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/ai-tool-reads-biopsy-images-predict-mantle-cell-lymphoma-outcomes</loc><lastmod>2026-10-27T13:00:00Z</lastmod><news:news><news:publication_date>2026-10-27T13:00:00Z</news:publication_date>
        <news:title><![CDATA[AI Tool Reads Biopsy Images to Predict Mantle Cell Lymphoma Outcomes]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/higher-ropeginterferon-alfa-2b-exposure-liked-to-jak2-reductions-in-et</loc><lastmod>2026-10-27T12:40:00Z</lastmod><news:news><news:publication_date>2026-10-27T12:40:00Z</news:publication_date>
        <news:title><![CDATA[Higher Ropeginterferon Alfa-2b Exposure Liked to JAK2 Reductions in ET]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/vitiligo-emergency-3-warning-signs-to-know</loc><lastmod>2026-10-27T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-27T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Vitiligo Emergency: 3 Warning Signs to Know]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/defining-treatment-failure-and-selecting-second-line-therapy-in-mcrc</loc><lastmod>2026-10-27T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-27T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Defining Treatment Failure and Selecting Second-Line Therapy in mCRC]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url><url>
      <loc>https://www.ajmc.com/view/weighing-pharmacy-savings-against-downstream-medical-costs-in-ckd</loc><lastmod>2026-10-27T12:05:00Z</lastmod><news:news><news:publication_date>2026-10-27T12:05:00Z</news:publication_date>
        <news:title><![CDATA[Weighing Pharmacy Savings Against Downstream Medical Costs in CKD]]></news:title>
        <news:keywords><![CDATA[]]></news:keywords>
      </news:news>
	</url></urlset>